Spotlight on solithromycin in the treatment of community-acquired bacterial pneumonia: design, development, and potential place in therapy

Community-acquired bacterial pneumonia (CABP) is a leading cause of death worldwide. However, antibacterial agents used to treat common pathogens in CABP are marked by adverse drug events and increasing antimicrobial resistance. Solithromycin is a new ketolide antibiotic, based on the macrolide anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Donald, Bryan J, Surani, Salim, Deol, Harmeet S, Mbadugha, Uche J, Udeani, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732564/
https://www.ncbi.nlm.nih.gov/pubmed/29263651
http://dx.doi.org/10.2147/DDDT.S119545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732564/
https://www.ncbi.nlm.nih.gov/pubmed/29263651
http://dx.doi.org/10.2147/DDDT.S119545

Ejemplares similares